NO842259L - Stabilisert produkt for multiparameterregulering - Google Patents

Stabilisert produkt for multiparameterregulering

Info

Publication number: NO842259L
Authority: NO; Norway
Prior art keywords: reagent; analytes; reagent according; enzymes; lactose
Prior art date: 1983-06-06

Application number

NO842259A

Other languages

English (en)

Norwegian (no)

Inventor

Michael Kevin Hoskins

Original Assignee

Ortho Diagnostic Systems Inc

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1983-06-06

Filing date

1984-06-05

Publication date

1984-12-07

1984-06-05 Application filed by Ortho Diagnostic Systems Inc filed Critical Ortho Diagnostic Systems Inc

1984-12-07 Publication of NO842259L publication Critical patent/NO842259L/no

Links

239000003153 chemical reaction reagent Substances 0.000 claims description 88
239000003381 stabilizer Substances 0.000 claims description 42
GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 claims description 38
238000000034 method Methods 0.000 claims description 38
239000008101 lactose Substances 0.000 claims description 35
102000004169 proteins and genes Human genes 0.000 claims description 27
108090000623 proteins and genes Proteins 0.000 claims description 27
102000004190 Enzymes Human genes 0.000 claims description 22
108090000790 Enzymes Proteins 0.000 claims description 22
235000000346 sugar Nutrition 0.000 claims description 22
230000002159 abnormal effect Effects 0.000 claims description 18
239000004599 antimicrobial Substances 0.000 claims description 17
230000000694 effects Effects 0.000 claims description 16
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 16
GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 claims description 15
GUBGYTABKSRVRQ-CUHNMECISA-N D-Cellobiose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-CUHNMECISA-N 0.000 claims description 11
FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 claims description 10
229930195725 Mannitol Natural products 0.000 claims description 10
239000000594 mannitol Substances 0.000 claims description 10
235000010355 mannitol Nutrition 0.000 claims description 10
OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 claims description 9
GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 claims description 9
-1 monosaccharide sugars Chemical class 0.000 claims description 9
WIIZWVCIJKGZOK-RKDXNWHRSA-N chloramphenicol Chemical compound ClC(Cl)C(=O)N[C@H](CO)[C@H](O)C1=CC=C([N+]([O-])=O)C=C1 WIIZWVCIJKGZOK-RKDXNWHRSA-N 0.000 claims description 8
229960005091 chloramphenicol Drugs 0.000 claims description 8
230000006641 stabilisation Effects 0.000 claims description 8
238000011105 stabilization Methods 0.000 claims description 8
GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 claims description 7
230000000813 microbial effect Effects 0.000 claims description 7
210000004369 blood Anatomy 0.000 claims description 6
239000008280 blood Substances 0.000 claims description 6
230000000087 stabilizing effect Effects 0.000 claims description 5
210000002966 serum Anatomy 0.000 claims description 4
210000001772 blood platelet Anatomy 0.000 claims 5
210000003743 erythrocyte Anatomy 0.000 claims 5
230000005764 inhibitory process Effects 0.000 claims 5
210000000265 leukocyte Anatomy 0.000 claims 5
239000007864 aqueous solution Substances 0.000 claims 2
125000003071 maltose group Chemical group 0.000 claims 2
239000000243 solution Substances 0.000 claims 2
239000000463 material Substances 0.000 description 21
239000000470 constituent Substances 0.000 description 16
238000007792 addition Methods 0.000 description 15
238000004108 freeze drying Methods 0.000 description 14
CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 10
DDRJAANPRJIHGJ-UHFFFAOYSA-N creatinine Chemical compound CN1CC(=O)NC1=N DDRJAANPRJIHGJ-UHFFFAOYSA-N 0.000 description 10
239000000126 substance Substances 0.000 description 9
150000008163 sugars Chemical class 0.000 description 8
238000012360 testing method Methods 0.000 description 8
CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 7
229930006000 Sucrose Natural products 0.000 description 7
239000005720 sucrose Substances 0.000 description 7
BPYKTIZUTYGOLE-IFADSCNNSA-N Bilirubin Chemical compound N1C(=O)C(C)=C(C=C)\C1=C\C1=C(C)C(CCC(O)=O)=C(CC2=C(C(C)=C(\C=C/3C(=C(C=C)C(=O)N\3)C)N2)CCC(O)=O)N1 BPYKTIZUTYGOLE-IFADSCNNSA-N 0.000 description 6
229910002092 carbon dioxide Inorganic materials 0.000 description 6
102000003855 L-lactate dehydrogenase Human genes 0.000 description 5
108700023483 L-lactate dehydrogenases Proteins 0.000 description 5
229940109239 creatinine Drugs 0.000 description 5
229940088598 enzyme Drugs 0.000 description 5
238000007710 freezing Methods 0.000 description 5
230000008014 freezing Effects 0.000 description 5
239000000203 mixture Substances 0.000 description 5
230000003287 optical effect Effects 0.000 description 5
235000018102 proteins Nutrition 0.000 description 5
230000008901 benefit Effects 0.000 description 4
HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 4
238000001694 spray drying Methods 0.000 description 4
239000012491 analyte Substances 0.000 description 3
230000000845 anti-microbial effect Effects 0.000 description 3
230000015556 catabolic process Effects 0.000 description 3
230000015271 coagulation Effects 0.000 description 3
238000005345 coagulation Methods 0.000 description 3
238000006731 degradation reaction Methods 0.000 description 3
150000002632 lipids Chemical class 0.000 description 3
238000003908 quality control method Methods 0.000 description 3
238000011084 recovery Methods 0.000 description 3
238000003860 storage Methods 0.000 description 3
238000010998 test method Methods 0.000 description 3
102100031126 6-phosphogluconolactonase Human genes 0.000 description 2
108010029731 6-phosphogluconolactonase Proteins 0.000 description 2
239000004382 Amylase Substances 0.000 description 2
102000013142 Amylases Human genes 0.000 description 2
108010065511 Amylases Proteins 0.000 description 2
102000001390 Fructose-Bisphosphate Aldolase Human genes 0.000 description 2
108010068561 Fructose-Bisphosphate Aldolase Proteins 0.000 description 2
WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
108010018962 Glucosephosphate Dehydrogenase Proteins 0.000 description 2
108010054147 Hemoglobins Proteins 0.000 description 2
102000001554 Hemoglobins Human genes 0.000 description 2
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 2
108010044467 Isoenzymes Proteins 0.000 description 2
239000003708 ampul Substances 0.000 description 2
235000019418 amylase Nutrition 0.000 description 2
238000004458 analytical method Methods 0.000 description 2
230000001580 bacterial effect Effects 0.000 description 2
210000001124 body fluid Anatomy 0.000 description 2
239000010839 body fluid Substances 0.000 description 2
239000001569 carbon dioxide Substances 0.000 description 2
235000012000 cholesterol Nutrition 0.000 description 2
229940107161 cholesterol Drugs 0.000 description 2
239000008103 glucose Substances 0.000 description 2
JYGXADMDTFJGBT-VWUMJDOOSA-N hydrocortisone Chemical compound O=C1CC[C@]2(C)[C@H]3[C@@H](O)C[C@](C)([C@@](CC4)(O)C(=O)CO)[C@@H]4[C@@H]3CCC2=C1 JYGXADMDTFJGBT-VWUMJDOOSA-N 0.000 description 2
JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
239000007788 liquid Substances 0.000 description 2
150000002772 monosaccharides Chemical class 0.000 description 2
239000013610 patient sample Substances 0.000 description 2
GZCWLCBFPRFLKL-UHFFFAOYSA-N 1-prop-2-ynoxypropan-2-ol Chemical compound CC(O)COCC#C GZCWLCBFPRFLKL-UHFFFAOYSA-N 0.000 description 1
108010044267 Abnormal Hemoglobins Proteins 0.000 description 1
102000013563 Acid Phosphatase Human genes 0.000 description 1
108010051457 Acid Phosphatase Proteins 0.000 description 1
102100036475 Alanine aminotransferase 1 Human genes 0.000 description 1
108010082126 Alanine transaminase Proteins 0.000 description 1
108010088751 Albumins Proteins 0.000 description 1
102000009027 Albumins Human genes 0.000 description 1
102000002260 Alkaline Phosphatase Human genes 0.000 description 1
108020004774 Alkaline Phosphatase Proteins 0.000 description 1
108010003415 Aspartate Aminotransferases Proteins 0.000 description 1
102000004625 Aspartate Aminotransferases Human genes 0.000 description 1
241000894006 Bacteria Species 0.000 description 1
BVKZGUZCCUSVTD-UHFFFAOYSA-M Bicarbonate Chemical compound OC([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-M 0.000 description 1
108091003079 Bovine Serum Albumin Proteins 0.000 description 1
OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
102100035882 Catalase Human genes 0.000 description 1
108010053835 Catalase Proteins 0.000 description 1
VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 1
102000003914 Cholinesterases Human genes 0.000 description 1
108090000322 Cholinesterases Proteins 0.000 description 1
102000004420 Creatine Kinase Human genes 0.000 description 1
108010042126 Creatine kinase Proteins 0.000 description 1
101150082208 DIABLO gene Proteins 0.000 description 1
101710088194 Dehydrogenase Proteins 0.000 description 1
102100033189 Diablo IAP-binding mitochondrial protein Human genes 0.000 description 1
LTMHDMANZUZIPE-AMTYYWEZSA-N Digoxin Natural products O([C@H]1[C@H](C)O[C@H](O[C@@H]2C[C@@H]3[C@@](C)([C@@H]4[C@H]([C@]5(O)[C@](C)([C@H](O)C4)[C@H](C4=CC(=O)OC4)CC5)CC3)CC2)C[C@@H]1O)[C@H]1O[C@H](C)[C@@H](O[C@H]2O[C@@H](C)[C@H](O)[C@@H](O)C2)[C@@H](O)C1 LTMHDMANZUZIPE-AMTYYWEZSA-N 0.000 description 1
238000008789 Direct Bilirubin Methods 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
108020004206 Gamma-glutamyltransferase Proteins 0.000 description 1
102000006395 Globulins Human genes 0.000 description 1
108010044091 Globulins Proteins 0.000 description 1
239000004366 Glucose oxidase Substances 0.000 description 1
108010015776 Glucose oxidase Proteins 0.000 description 1
108010023302 HDL Cholesterol Proteins 0.000 description 1
102000008133 Iron-Binding Proteins Human genes 0.000 description 1
108010035210 Iron-Binding Proteins Proteins 0.000 description 1
AYRXSINWFIIFAE-SCLMCMATSA-N Isomaltose Natural products OC[C@H]1O[C@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)[C@@H](O)[C@@H](O)[C@@H]1O AYRXSINWFIIFAE-SCLMCMATSA-N 0.000 description 1
COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
JVTAAEKCZFNVCJ-UHFFFAOYSA-M Lactate Chemical compound CC(O)C([O-])=O JVTAAEKCZFNVCJ-UHFFFAOYSA-M 0.000 description 1
108090001060 Lipase Proteins 0.000 description 1
102000004882 Lipase Human genes 0.000 description 1
239000004367 Lipase Substances 0.000 description 1
WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
241001465754 Metazoa Species 0.000 description 1
OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
102100028255 Renin Human genes 0.000 description 1
108090000783 Renin Proteins 0.000 description 1
240000004808 Saccharomyces cerevisiae Species 0.000 description 1
238000008050 Total Bilirubin Reagent Methods 0.000 description 1
239000013504 Triton X-100 Substances 0.000 description 1
229920004890 Triton X-100 Polymers 0.000 description 1
LEHOTFFKMJEONL-UHFFFAOYSA-N Uric Acid Chemical compound N1C(=O)NC(=O)C2=C1NC(=O)N2 LEHOTFFKMJEONL-UHFFFAOYSA-N 0.000 description 1
TVWHNULVHGKJHS-UHFFFAOYSA-N Uric acid Natural products N1C(=O)NC(=O)C2NC(=O)NC21 TVWHNULVHGKJHS-UHFFFAOYSA-N 0.000 description 1
PNNCWTXUWKENPE-UHFFFAOYSA-N [N].NC(N)=O Chemical compound [N].NC(N)=O PNNCWTXUWKENPE-UHFFFAOYSA-N 0.000 description 1
238000010521 absorption reaction Methods 0.000 description 1
230000002411 adverse Effects 0.000 description 1
230000009286 beneficial effect Effects 0.000 description 1
238000009835 boiling Methods 0.000 description 1
229940098773 bovine serum albumin Drugs 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000011575 calcium Substances 0.000 description 1
229910052791 calcium Inorganic materials 0.000 description 1
229920002301 cellulose acetate Polymers 0.000 description 1
230000008859 change Effects 0.000 description 1
239000003795 chemical substances by application Substances 0.000 description 1
229940048961 cholinesterase Drugs 0.000 description 1
KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Substances OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 1
150000001875 compounds Chemical class 0.000 description 1
238000011109 contamination Methods 0.000 description 1
238000007796 conventional method Methods 0.000 description 1
239000013256 coordination polymer Substances 0.000 description 1
230000009849 deactivation Effects 0.000 description 1
238000000354 decomposition reaction Methods 0.000 description 1
230000007423 decrease Effects 0.000 description 1
230000007812 deficiency Effects 0.000 description 1
238000003745 diagnosis Methods 0.000 description 1
229960005156 digoxin Drugs 0.000 description 1
LTMHDMANZUZIPE-PUGKRICDSA-N digoxin Chemical compound C1[C@H](O)[C@H](O)[C@@H](C)O[C@H]1O[C@@H]1[C@@H](C)O[C@@H](O[C@@H]2[C@H](O[C@@H](O[C@@H]3C[C@@H]4[C@]([C@@H]5[C@H]([C@]6(CC[C@@H]([C@@]6(C)[C@H](O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)C[C@@H]2O)C)C[C@@H]1O LTMHDMANZUZIPE-PUGKRICDSA-N 0.000 description 1
LTMHDMANZUZIPE-UHFFFAOYSA-N digoxine Natural products C1C(O)C(O)C(C)OC1OC1C(C)OC(OC2C(OC(OC3CC4C(C5C(C6(CCC(C6(C)C(O)C5)C=5COC(=O)C=5)O)CC4)(C)CC3)CC2O)C)CC1O LTMHDMANZUZIPE-UHFFFAOYSA-N 0.000 description 1
150000002016 disaccharides Chemical class 0.000 description 1
238000010494 dissociation reaction Methods 0.000 description 1
230000005593 dissociations Effects 0.000 description 1
238000001962 electrophoresis Methods 0.000 description 1
230000005496 eutectics Effects 0.000 description 1
238000001914 filtration Methods 0.000 description 1
238000009472 formulation Methods 0.000 description 1
102000006640 gamma-Glutamyltransferase Human genes 0.000 description 1
239000007789 gas Substances 0.000 description 1
229940116332 glucose oxidase Drugs 0.000 description 1
235000019420 glucose oxidase Nutrition 0.000 description 1
229960000890 hydrocortisone Drugs 0.000 description 1
125000002887 hydroxy group Chemical group [H]O* 0.000 description 1
230000000260 hypercholesteremic effect Effects 0.000 description 1
230000001227 hypertriglyceridemic effect Effects 0.000 description 1
238000001727 in vivo Methods 0.000 description 1
229960004903 invert sugar Drugs 0.000 description 1
229910052742 iron Inorganic materials 0.000 description 1
DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
108010087599 lactate dehydrogenase 1 Proteins 0.000 description 1
239000004310 lactic acid Substances 0.000 description 1
235000014655 lactic acid Nutrition 0.000 description 1
235000019421 lipase Nutrition 0.000 description 1
229910052744 lithium Inorganic materials 0.000 description 1
210000004185 liver Anatomy 0.000 description 1
239000011777 magnesium Substances 0.000 description 1
229910052749 magnesium Inorganic materials 0.000 description 1
238000004519 manufacturing process Methods 0.000 description 1
238000005259 measurement Methods 0.000 description 1
COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
239000011574 phosphorus Substances 0.000 description 1
229910052698 phosphorus Inorganic materials 0.000 description 1
229920000642 polymer Polymers 0.000 description 1
239000011591 potassium Substances 0.000 description 1
229910052700 potassium Inorganic materials 0.000 description 1
239000000843 powder Substances 0.000 description 1
238000002360 preparation method Methods 0.000 description 1
230000008569 process Effects 0.000 description 1
230000001681 protective effect Effects 0.000 description 1
238000012797 qualification Methods 0.000 description 1
230000009467 reduction Effects 0.000 description 1
239000000523 sample Substances 0.000 description 1
ABBQHOQBGMUPJH-UHFFFAOYSA-N sodium;2-hydroxybenzoic acid Chemical compound [Na+].OC(=O)C1=CC=CC=C1O ABBQHOQBGMUPJH-UHFFFAOYSA-N 0.000 description 1
239000004094 surface-active agent Substances 0.000 description 1
150000003626 triacylglycerols Chemical class 0.000 description 1
229940116269 uric acid Drugs 0.000 description 1

Landscapes

Investigating Or Analysing Biological Materials (AREA)
Control Of Temperature (AREA)
Vehicle Cleaning, Maintenance, Repair, Refitting, And Outriggers (AREA)
Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)

NO842259A 1983-06-06 1984-06-05 Stabilisert produkt for multiparameterregulering NO842259L (no)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US50135883A	1983-06-06	1983-06-06

Publications (1)

Publication Number	Publication Date
NO842259L true NO842259L (no)	1984-12-07

Family

ID=23993229

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO842259A NO842259L (no)	1983-06-06	1984-06-05	Stabilisert produkt for multiparameterregulering

Country Status (6)

Country	Link
JP (1)	JPS6040960A (fr)
AU (1)	AU583790B2 (fr)
CA (1)	CA1226794A (fr)
DK (1)	DK275284A (fr)
IL (1)	IL72031A0 (fr)
NO (1)	NO842259L (fr)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA1226795A (fr) *	1983-06-06	1987-09-15	Michael K. Hoskins	Produits de controle stabilises de la coagulation
CA1230300A (fr) *	1983-06-06	1987-12-15	Michael K. Hoskins	Isoenzyme de controle stabilise
US4663295A (en) *	1983-06-29	1987-05-05	Ciba Corning Diagnostics Corp.	Estrogen-progesterone control reagents and methods for making same
US4711852A (en) *	1984-11-05	1987-12-08	Akzo N.V.	Control for blood gas analyzers and hemoglobin analysis
JPS62244596A (ja) *	1986-04-17	1987-10-24	Nippon Steel Corp	被覆ア−ク溶接棒

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JPS51144724A (en) *	1975-06-10	1976-12-13	Shinotesuto Kenkyusho:Kk	A process for preparing alpha-fetoprotein standard serum which is usable for a long time
JPS556247A (en) *	1978-06-30	1980-01-17	Eiken Kagaku Kk	Abnormal range administrating blood serum for thymol kunckel
CA1226795A (fr) *	1983-06-06	1987-09-15	Michael K. Hoskins	Produits de controle stabilises de la coagulation
CA1230300A (fr) *	1983-06-06	1987-12-15	Michael K. Hoskins	Isoenzyme de controle stabilise
US4663295A (en) *	1983-06-29	1987-05-05	Ciba Corning Diagnostics Corp.	Estrogen-progesterone control reagents and methods for making same

1984
- 1984-05-25 CA CA000455085A patent/CA1226794A/fr not_active Expired
- 1984-06-04 DK DK275284A patent/DK275284A/da not_active Application Discontinuation
- 1984-06-04 JP JP11322584A patent/JPS6040960A/ja active Pending
- 1984-06-05 NO NO842259A patent/NO842259L/no unknown
- 1984-06-05 IL IL72031A patent/IL72031A0/xx unknown
- 1984-06-05 AU AU29087/84A patent/AU583790B2/en not_active Ceased

Also Published As

Publication number	Publication date
CA1226794A (fr)	1987-09-15
AU2908784A (en)	1984-12-13
DK275284D0 (da)	1984-06-04
IL72031A0 (en)	1984-10-31
AU583790B2 (en)	1989-05-11
DK275284A (da)	1984-12-07
JPS6040960A (ja)	1985-03-04

Publication	Publication Date	Title
Wilbrandt	1937	A relation between the permeability of the red cell and its metabolism
JP2726726B2 (ja)	1998-03-11	血液ガス／カルシウム分析機器用対照液
RU2670956C9 (ru)	2018-11-21	Раствор тромбина и способы его применения
NO842259L (no)	1984-12-07	Stabilisert produkt for multiparameterregulering
US5298406A (en)	1994-03-29	Formulation for stabilizing enzymatic activity and immunoreactivity of creatine kinase and creatine kinase isoenzymes
DK158409B (da)	1990-05-14	Fremgangsmaade til fremstilling af justerings- eller kontrolsera med ringe uklarhed.
US5700653A (en)	1997-12-23	Liquid stable thiol activator
CN101698880A (zh)	2010-04-28	血清钠离子酶法定量测定试剂盒及其制备方法和其检测方法
EP0130708A1 (fr)	1985-01-09	Réactifs de contrôle cliniques stabilisés
JPH0476066B2 (fr)	1992-12-02
EP0351117B1 (fr)	1995-02-22	Témoin stable de contrôle à base de sérum humain
US4684615A (en)	1987-08-04	Stabilized isoenzyme control products
CA1230300A (fr)	1987-12-15	Isoenzyme de controle stabilise
JP2558450B2 (ja)	1996-11-27	キサンチンオキシダ−ゼの安定化方法
JPH09509064A (ja)	1997-09-16	イソ酵素キャリブレーター／コントロール製品
JP2024174300A (ja)	2024-12-17	乾燥用保護剤、生体試料測定試薬、及び分析方法
WO2010101206A1 (fr)	2010-09-10	Agent stabilisant pour échantillon de gestion, échantillon de gestion contenant l'agent stabilisant, et kit de mesure comprenant l'échantillon de gestion
JP4565311B2 (ja)	2010-10-20	酵素の安定化方法および組成物
JP4544598B2 (ja)	2010-09-15	液状試薬および保存方法
Akköse	2018	Effect of various biopolymers on glass transition temperature of chicken breast meat
Waldstein et al.	1964	Determination of Exogenous Galactose in Blood using" Specially Purified" Glucose Oxidase
JP4288559B2 (ja)	2009-07-01	アスコルビン酸オキシダーゼの安定化方法および安定化組成物
KR20040095275A (ko)	2004-11-12	알라닌 아미노트랜스퍼라아제 활성 측정 시약
JPS59166084A (ja)	1984-09-19	安定な酵素試薬の製造法
US3410757A (en)	1968-11-12	Galactose test composition and method